Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2017

Open Access 01-12-2017 | Research article

Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature

Authors: Hanin Kamaruzaman, Philip Kinghorn, Raymond Oppong

Published in: BMC Musculoskeletal Disorders | Issue 1/2017

Login to get access

Abstract

Background

The primary purpose of this study is to assess the existing evidence on the cost-effectiveness of surgical interventions for the management of knee and hip osteoarthritis by systematically reviewing published economic evaluation studies.

Methods

A systematic review was conducted for the period 2004 to 2016. Electronic databases were searched to identify both trial and model based economic evaluation studies that evaluated surgical interventions for knee and hip osteoarthritis.

Results

A total of 23 studies met the inclusion criteria and an assessment of these studies showed that total knee arthroplasty (TKA), and total hip arthroplasty (THA) showed evidence of cost-effectiveness and improvement in quality of life of the patients when compared to non-operative and non-surgical procedures. On the other hand, even though delaying TKA and THA may lead to some cost savings in the short-run, the results from the study showed that this was not a cost-effective option.

Conclusions

TKA and THA are cost-effective and should be recommended for the management of patients with end stage/severe knee and hip OA. However, there needs to be additional studies to assess the cost-effectiveness of other surgical interventions in order for definite conclusions to be reached.
Appendix
Available only for authorised users
Literature
1.
Wang TJ, et al. Effects of aquatic exercise on flexibility, strength and aerobic fitness in adults with osteoarthritis of the hip or knee. J Adv Nurs. 2007;57(2):141–52.CrossRefPubMed
2.
3.
4.
5.
Le TK, et al. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Res. 2012;5:23–30.PubMedPubMedCentral
6.
7.
Kotlarz H, et al. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheumatol. 2009;60(12):3546–53.CrossRef
8.
9.
Hilismann, M., et al., Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in arthritis and rheumatism, 2013: p. 303-313.
10.
Kurtz SM, et al. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467:2606–12.CrossRefPubMedPubMedCentral
11.
Piscitelli P, et al. Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: a 5-year analysis based on hospitalization records. Arthritis Care Res. 2012;64:1320–7.CrossRef
12.
Pinto D, et al. Cost-effectiveness of nonpharmacologic, nonsurgical interventions for hip and/or knee osteoarthritis: systematic review. Value Health. 2012;15(1):1–12.CrossRefPubMed
13.
Wielage RC, et al. Cost-effectiveness analyses of osteoarthritis oral therapies: a systematic review. Appl Health Econ Health Policy. 2013;11(6):593–618.CrossRefPubMed
14.
Xie F, et al. Cost-effectiveness of pharmaceutical management for osteoarthritis pain. Drugs Aging. 2013;30(5):277–84.CrossRefPubMed
15.
Husereau D, et al. Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–50.CrossRefPubMed
16.
Philips Z, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assessment. 2004;8:36.CrossRef
17.
Ofman JJ, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm. 2003;9(1):53–61.PubMed
18.
Bedair H, Cha TD, Hansen VJ. Economic benefit to society at large of total knee arthroplasty in younger patients. J Bone Joint Surg Am. 2014;96(2):119–26.CrossRefPubMed
19.
Marsh JD, et al. Cost-effectiveness analysis of arthroscopic surgery compared with non-operative management for osteoarthritis of the knee. BMJ open. 2016;6(1):e009949.CrossRefPubMedPubMedCentral
20.
Mather RC, et al. Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. BMC Musculoskelet Disord. 2014;15(1):1.CrossRef
21.
Koskinen E, et al. Comparison of survival and cost-effectiveness between unicondylar arthroplasty and total knee arthroplasty in patients with primary osteoarthritis: a follow-up study of 50,493 knee replacements from the Finnish Arthroplasty Register. Acta Orthopaedica. 2008;79(4):499–507.CrossRefPubMed
22.
Li CS, et al. Cost-effectiveness and economic impact of the KineSpring® Knee Implant System in the treatment for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2013;21(11):2629–37.CrossRefPubMed
23.
Pennington M, Grieve R, van der Meulen JH. Lifetime cost effectiveness of different brands of prosthesis used for total hip arthroplasty a study using the NJR dataset. Bone Joint J. 2015;97(6):762–70.CrossRefPubMed
24.
Stan G, Orban H, Orban C. Cost effectiveness analysis of knee osteoarthritis treatment. Chirurgia. 2015;110:368–74.PubMed
25.
Soohoo NF, et al. Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. J Bone Joint Surg. 2006;88(9):1975–82.PubMed
26.
27.
Xie F, et al. Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study. Eur J Health Econ. 2010;11(1):27–34.CrossRefPubMed
28.
Räsänen P, et al. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop. 2007;78(1):108–15.CrossRefPubMed
29.
Bozic KJ, et al. Do the potential benefits of metal-on-metal hip resurfacing justify the increased cost and risk of complications? Clin Orthop Relat Res. 2010;468(9):2301–12.CrossRefPubMedPubMedCentral
30.
Bellamy N, et al. Validation study of a computerized version of the Western Ontario and McMaster Universities VA3. 0 Osteoarthritis Index. J Rheumatol. 1997;24(12):2413–5.PubMed
31.
Ruiz D, et al. The direct and indirect costs to society of treatment for end-stage knee osteoarthritis. J Bone Joint Surg Am. 2013;95(16):1473–80.CrossRefPubMed
32.
Waimann CA, et al. Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res. 2014;66(4):592–9.CrossRef
33.
Konopka JF, et al. The cost-effectiveness of surgical treatment of medial unicompartmental knee osteoarthritis in younger patients. J Bone Joint Surg Am. 2015;97(10):807–17.CrossRefPubMedPubMedCentral
34.
Peersman G, et al. Cost-effectiveness of unicondylar versus total knee arthroplasty: a Markov model analysis. Knee. 2014;21:S37–42.CrossRefPubMed
35.
Higashi H, Barendregt JJ. Cost-effectiveness of total hip and knee replacements for the Australian population with osteoarthritis: discrete-event simulation model. PLoS One. 2011;6(9):e25403.CrossRefPubMedPubMedCentral
36.
Losina E, et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med. 2009;169(12):1113.CrossRefPubMedPubMedCentral
37.
Heintzbergen S, et al. Cost-utility of metal-on-metal hip resurfacing compared to conventional total hip replacement in young active patients with osteoarthritis. Value Health. 2013;16(6):942–52.CrossRefPubMed
38.
Mota R. Cost-effectiveness analysis of early versus late total hip replacement in Italy. Value Health. 2013;16(2):267–79.CrossRefPubMed
39.
Di Tanna GL, et al. Modeling the cost-effectiveness for cement-less and hybrid prosthesis in total hip replacement in Emilia Romagna, Italy. J Surg Res. 2011;169(2):227–33.CrossRefPubMed
40.
Pulikottil-Jacob R, et al. Cost effectiveness of total hip arthroplasty in osteoarthritis comparison of devices with differing bearing surfaces and modes of fixation. Bone Joint J. 2015;97(4):449–57.CrossRefPubMed
41.
Pennington M, et al., Cemented, cementless, and hybrid prostheses for total hip replacement: cost effectiveness analysis. BMJ, 2013. 346 doi:10.​1136/​bmj.​f1026
42.
Griffin S, Claxton K. Analyzing uncertainty in cost-effectiveness for decision-making. In: Glied S, Smith PC, editors. The Oxford Handbook of Health Economics. New York: Oxford University Press; 2011. p. 759–87.
43.
Soohoo N, Kominski G. Cost-effectiveness analysis of total ankle arthroplasty. J Bone Joint Surg Am. 2004;86(11):2446–55.CrossRefPubMed
44.
Sonnenberg FA, Beck JR. Markov models in medical decision making a practical guide. Med Decis Mak. 1993;13(4):322–38.CrossRef
45.
Barton P, Bryan S, Robinson S. Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy. 2004;9(2):110–8.CrossRefPubMed
46.
Caro J. Pharmacoeconomic analyses using discrete event simulation. PharmacoEconomics. 2005;23(4):323–32.CrossRefPubMed
47.
Hughes D, et al. Conducting economic evaluations alongside randomised trials: current methodological issues and novel approaches. PharmacoEconomics. 2016;34(5):447–61.CrossRefPubMed
48.
Koopmanschap MA, Touw KC, Rutten FF. Analysis of costs and cost-effectiveness in multinational trials. Health Policy. 2001;58(2):175–86.CrossRefPubMed
49.
Barbieri M, et al. What do international pharmacoeconomic guidelines say about economic data transferability? Value Health. 2010;13(8):1028–37.CrossRefPubMed
50.
Oppong R, Jowett S, Roberts TE. Economic evaluation alongside multinational studies: a systematic review of empirical studies. PloS One. 2015;10(6):e0131949.CrossRefPubMedPubMedCentral
51.
52.
Hiligsmann M, et al. A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44:271–82.CrossRefPubMed
53.
Metadata
Title
Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature
Authors
Hanin Kamaruzaman
Philip Kinghorn
Raymond Oppong
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2017
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-017-1540-2

Other articles of this Issue 1/2017

BMC Musculoskeletal Disorders 1/2017 Go to the issue

Research article

Angiomatoid fibrous histiocytoma: a series of seven cases including genetically confirmed aggressive cases and a literature review

Research article

The effectiveness of interventions aimed at increasing physical activity in adults with persistent musculoskeletal pain: a systematic review and meta-analysis

Research article

Sedentary behaviour is associated with increased long-term cardiovascular risk in patients with rheumatoid arthritis independently of moderate-to-vigorous physical activity

Research article

Contradictory individualized self-blaming: a cross-sectional study of associations between expectations to managers, coworkers, one-self and risk factors for musculoskeletal disorders among construction workers

Research article

Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice

Research article

Rheumatoid factors do not predict cardiovascular disease and mortality in the general population in the Busselton Health Survey